- 23 May
Datopotamab Deruxtecan Wins FDA Approval for First-Line TNBC
Datopotamab deruxtecan has a second US breast cancer green light now.
Read More10% Discount on Manual & Electric Hospital Beds - Starting from 3 July!
Datopotamab deruxtecan has a second US breast cancer green light now.
Read MorePulse Biosciences Nanosecond PFA Cuts AFib Failure to 5% Pulse Bios
Read MoreA new WHO Europe AI health report shows artificial intelligence is now
Read MoreEphA2 Minibody PET Imaging Lights Up Cancer Tumors A new EphA2 mini
Read MoreAI-Powered AF Detection Headlines HRS 2026 Panel AI-powered AF dete
Read MoreSelf-Organizing Pencil Beam Imaging Speeds Brain Scans A new self-o
Read MoreStem Cell Insulin Therapy Reverses Diabetes in Mice A new stem cell
Read MoreLight-Based Cancer Biomarker Sensor Catches Early Signals A new lig
Read MoreA new intravascular ECM biomaterial may calm inflammation. It could re
Read MoreAnaemia Dementia Risk Study Flags Haemoglobin as Warning Sign A ne
Read MoreAdding cannabidiol (CBD; Epidiolex) to standard care eased the behavio
Read MoreHigh lipoprotein(a) levels are linked to a sharply higher risk of majo
Read MoreDoctors using a subcutaneous implantable cardioverter-defibrillator (S
Read MoreA new study points to a protein that may decide whether colorectal can
Read MoreEU agencies have backed wider use of three oncology drugs. The new EMA
Read MoreThe American College of Physicians (ACP) now urges biennial mammograph
Read MoreA new study describes how AI melanoma risk prediction can sort people
Read MoreThe global medical equipment industry is evolving rapidly, and the rec
Read MoreWhat Is Cardiometabolic Disease? Cardiometabolic disease is a group
Read MoreA new global report has warned that efforts to combat antimicrobial re
Read More